Valuation: Kenvue Inc.

Market Cap 37.4B 32.72B 30.18B 27.87B 52.88B 3,567B 53.77B 361B 142B 1,757B 140B 137B 6,041B P/E 2026 *
20.4x
P/E 2027 * 18.2x
Enterprise Value 44.81B 39.19B 36.15B 33.39B 63.36B 4,274B 64.42B 432B 170B 2,105B 168B 165B 7,237B EV / Sales 2026 *
2.87x
EV / Sales 2027 * 2.76x
Free-Float
98.9%
Yield 2026 *
4.36%
Yield 2027 * 4.45%
1 day+1.56%
1 week-1.77%
Current month+1.94%
1 month+7.39%
3 months+12.28%
6 months+14.59%
Current year+12.93%
1 week 19.04
Extreme 19.04
20.13
1 month 17.86
Extreme 17.855
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.61
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
06-28
Starboard Value LP
OtherCompany 1,413 0.0001%
06-28Free

Director

1,413 0.0001%
06-09Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%-1.77%-8.72%-22.85% 37.4B
+0.13%-2.89%-6.37%-1.22% 342B
+1.05%-0.45%-8.79%+2.62% 133B
+1.35%-3.04%+2.97%+22.72% 73.81B
+0.28%-2.30%-14.65%-19.56% 52.98B
+0.82%-1.25%-9.24%-56.73% 29.91B
+0.25%-0.14%+5.95%0.00% 19.56B
+1.43%+1.70%-28.77%-32.94% 19.44B
+0.40%-2.86%-0.75%+21.34% 18.03B
+0.09%+1.07%-15.30%+1.88% 11.68B
Average +0.74%-1.12%-8.37%-8.47% 73.86B
Weighted average by Cap. +0.57%-2.02%-6.97%-2.99%

Financials

2026 *2027 *
Net sales 15.63B 13.67B 12.61B 11.65B 22.1B 1,491B 22.47B 151B 59.18B 734B 58.69B 57.42B 2,525B 16.03B 14.02B 12.93B 11.94B 22.66B 1,529B 23.04B 155B 60.68B 753B 60.18B 58.87B 2,589B
Net income 1.84B 1.61B 1.49B 1.37B 2.61B 176B 2.65B 17.77B 6.98B 86.59B 6.92B 6.77B 298B 2.06B 1.81B 1.67B 1.54B 2.92B 197B 2.97B 19.9B 7.82B 97.01B 7.75B 7.58B 334B
Net Debt 7.41B 6.48B 5.98B 5.52B 10.47B 706B 10.65B 71.4B 28.04B 348B 27.81B 27.2B 1,196B 6.81B 5.96B 5.5B 5.08B 9.63B 650B 9.79B 65.66B 25.78B 320B 25.57B 25.02B 1,100B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-10 US$19.48 +1.56% 9,451,591
26-07-09 US$19.18 -0.57% 14,446,508
26-07-08 US$19.29 -2.48% 12,756,324
26-07-07 US$19.78 +1.12% 16,317,432
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.48USD
Average target price
19.58USD
Spread / Average Target
+0.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock